Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS2 | Q9H2K2 | 9/20 | 0.61 |
| ▸ | PARP1 | P09874 | 5/20 | 0.61 |
| ▸ | QTRT1 | Q9BXR0 | 1/20 | 0.61 |
| ▸ | TNKS | O95271 | 7/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.53 |
| ▸ | TUBB | P07437 | 1/20 | 0.53 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.53 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.53 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.53 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.53 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.53 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.53 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.53 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.53 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.53 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29419642 | 1.00 | TNKS2 (0.61) | TNKS2PARP1QTRT1TNKSPKM | |
| SCHEMBL38651997 | 0.98 | TNKS2 (0.59) | TNKS2PARP1QTRT1TNKSPKM | |
| SCHEMBL6695759 | 0.79 | TNKS2 (0.81) | TNKS2PARP1QTRT1TNKSPKM | |
| Benzoylenurea SCHEMBL5110914 | 0.76 | TNKS2 (0.61) | TNKS2PARP1QTRT1TNKSPKM | |
| SCHEMBL22021640 | 0.76 | TNKS2 (0.61) | TNKS2PARP1QTRT1TNKSPKM | |
| SCHEMBL1772523 | 0.76 | TNKS2 (0.61) | TNKS2PARP1QTRT1TNKSPKM | |
| SCHEMBL103994 | 0.76 | QTRT1 (1.00) | TNKS2PARP1QTRT1TNKSPKM | |
| SCHEMBL22807316 | 0.76 | TNKS2 (0.61) | TNKS2PARP1QTRT1TNKSPKM | |
| SCHEMBL31070302 | 0.76 | TNKS2 (0.61) | TNKS2PARP1QTRT1TNKSPKM | |
| SCHEMBL146025 | 0.76 | TNKS2 (0.61) | TNKS2PARP1QTRT1TNKSPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 427 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1673663-B1 | LIGHT SENSITIVE COATING COMPOSITIONS FOR LITHOGRAPHIC ELEMENTS | IBF IND BRASILEIRA DE FILMES SA (BR) | 2011-03-23 | — | — | EP | claimed |
| US-20070202434-A1 | Light Sensitive Coating Compositions Useful For Lithographic Elements | IBF INDUSTRIA BRASILEIRA DE FILMES S/A (BR) | 2007-08-30 | — | — | US | claimed |
| EP-1673663-A1 | LIGHT SENSITIVE COATING COMPOSITIONS USEFUL FOR LITHOGRAPHIC ELEMENTS | IBF Industria Brasileira de Filmes Ltda. (BR) | 2006-06-28 | — | — | EP | claimed |
| WO-2005029186-A1 | LIGHT SENSITIVE COATING COMPOSITIONS USEFUL FOR LITHOGRAPHIC ELEMENTS | IBF Indústria Brasileira de Filmes Ltda. (BR) | 2005-03-31 | — | — | WO | claimed |
| US-4985470-A | Three component photoinitiator system, printing plates, photoresists, inks, paints, adhesives | MITSUBISHI KASEI CORPORATION (JP) | 1991-01-15 | — | — | US | claimed |
| US-6423486-B1 | — | — | None | — | — | US | disclosed |
| JP-60075488-A | — | — | None | — | — | JP | disclosed |
| US-20250146050-A1 | STABILISATION OF BIOLOGICAL SAMPLES | QIAGEN GMBH (DE) | 2025-05-08 | — | — | US | disclosed |
| US-20250122555-A1 | STABILISATION OF BIOLOGICAL SAMPLES | QIAGEN GMBH (DE) | 2025-04-17 | — | — | US | disclosed |
| US-12139744-B2 | Stabilisation of biological samples | QIAGEN GMBH (DE) | 2024-11-12 | — | — | US | disclosed |
| WO-2024190527-A1 | COLORED CURABLE RESIN COMPOSITION, OPTICAL FILTER AND SOLID-STATE IMAGING ELEMENT | 住友化学株式会社 | 2024-09-19 | — | — | WO | disclosed |
| WO-2024190526-A1 | COLORED CURABLE RESIN COMPOSITION, OPTICAL FILTER, AND SOLID-STATE IMAGING ELEMENT | 住友化学株式会社 | 2024-09-19 | — | — | WO | disclosed |
| US-4329363-A | Substituted mercapto acid amides and their use | MERCK & CO., INC. (US) | 1982-05-11 | — | — | US | disclosed |
| US-4329347-A | Cardiotonic and antithrombotic sulfur-containing derivatives of carbostyril | BOEHRINGER INGELHEIM GMBH (DE) | 1982-05-11 | — | — | US | disclosed |
| US-4302585-A | IMMUNOSUPRESSANTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1981-11-24 | — | — | US | disclosed |
| US-4294920-A | PEPTIZATION, PROTECTIVE COLLOIDS | AGFA-GEVAERT AKTIENGESELLSCHAFT (DE) | 1981-10-13 | — | — | US | disclosed |
| US-4278793-A | ANTIBIOTICS, BACTERICIDES | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-07-14 | — | — | US | disclosed |
| EP-0005200-B1 | SILVER HALIDE PHOTOGRAPHIC MATERIAL AND METHOD OF PREPARATION | Agfa-Gevaert AG (DE) | 1981-04-15 | — | — | EP | disclosed |
| US-4216160-A | IMMUNOREGULANTS FOR CORRECTING AN INBALANCE OF IMMUNE HOMEOSTASIS | MERCK & CO., INC. (US) | 1980-08-05 | — | — | US | disclosed |
| EP-0005200-A2 | Silver halide photographic material and method of preparation | Agfa-Gevaert AG (DE) | 1979-11-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250122555-A1 | STABILISATION OF BIOLOGICAL SAMPLES | RNASE1, RNASEH1, EWSR1 | TNKS2 900/4885PARP1 555/4885QTRT1 4536/4885 |
| US-12139744-B2 | Stabilisation of biological samples | RNASE1, RNASEH1, EWSR1 | TNKS2 900/4885PARP1 555/4885QTRT1 4536/4885 |
| US-20250146050-A1 | STABILISATION OF BIOLOGICAL SAMPLES | RNASE1, RNASEH1, EWSR1 | TNKS2 900/4885PARP1 555/4885QTRT1 4536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.